Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn:
“It was a distinct honor for me to be invited to speak as Visiting Professor for the day at University of Nebraska Hematology Grand Rounds at the Fred and Pamela Buffett Cancer Center! I was able to give Grand Rounds on “Clinical Updates in Myeloproliferative Neoplasms (MPNs) for 2025 and Beyond”.
A huge thank you to the hematology team in OMAHA for so graciously hosting me and for the wonderful, timely and relevant exchange of ideas together.”
More posts featuring Naveen Pemmaraju on OncoDaily.
